These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25743131)

  • 21. Modeling of hematologic malignancies by iPS technology.
    Arai S; Miyauchi M; Kurokawa M
    Exp Hematol; 2015 Aug; 43(8):654-60. PubMed ID: 26135030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism.
    Nagata N; Yamanaka S
    Circ Res; 2014 Jan; 114(3):505-10. PubMed ID: 24481841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low pH reprograms somatic murine cells into pluripotent stem cells: a novel technique with therapeutic implications.
    Williams JS; Xiao Y; Brownell I
    Cancer Biol Ther; 2014 Jun; 15(6):675-7. PubMed ID: 24618709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human iPSC Generation from Antigen-Specific T Cells.
    Nishimura T; Murmann Y; Nakauchi H
    Methods Mol Biol; 2019; 2048():53-57. PubMed ID: 31396928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunogenicity of cells derived from induced pluripotent stem cells.
    Fu X
    Cell Mol Immunol; 2014 Jan; 11(1):14-6. PubMed ID: 24336164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune cells derived from induced pluripotent stem cells: a new cell source for cancer immunotherapy].
    Ueda N; Kaneko S
    Nihon Rinsho; 2017 Feb; 75(2):317-322. PubMed ID: 30562871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells in companion animals: how can we move the field forward?
    Barrachina L; Arshaghi TE; O'Brien A; Ivanovska A; Barry F
    Front Vet Sci; 2023; 10():1176772. PubMed ID: 37180067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reprogramming away from the exhausted T cell state.
    Karagiannis P; Iriguchi S; Kaneko S
    Semin Immunol; 2016 Feb; 28(1):35-44. PubMed ID: 26589493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.
    Nishimura T; Nakauchi H
    Methods Mol Biol; 2019; 1899():25-40. PubMed ID: 30649763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy.
    Patel SJ; Yamauchi T; Ito F
    Surg Oncol Clin N Am; 2019 Jul; 28(3):489-504. PubMed ID: 31079802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comment on pluripotent stem cells in next-generation biomedical theranostics.
    Rossbach M
    Curr Mol Med; 2013 Jun; 13(5):879-83. PubMed ID: 23642068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.
    Nair M; Sandhu SS; Sharma AK
    Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Reprogramming Techniques: Contributions to Cancer Therapy.
    Guo T; Wei Q
    Cell Reprogram; 2023 Aug; 25(4):142-153. PubMed ID: 37530737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.